In the Netherlands prenatal screening is offered as a mean to increase reproductive choices of couples. All women are counseled on the existing options by trained midwives. The government puts a great emphasis on informed choice and on womens’ opinions and reactions to screenings options. Since 2017 non-invasive prenatal testing (NIPT, cf-DNA) is offered as first tier screening for aneuploidies in the genome-wide (GW) variant at the cost of 175 Euro’s. Uptake is around 50%. This screenings offer is perceived as unconventional for the traditionally cautious Dutch system.

中文翻译：

---

无创产前检测（NIPT）在荷兰的实施

在荷兰，产前筛查是增加夫妻生育选择的一种手段。受过训练的助产士会就现有选择向所有妇女提供咨询。政府非常重视知情选择以及女性对筛查选项的意见和反应。自 2017 年以来，无创产前检测（NIPT、cf-DNA）作为全基因组 (GW) 变异中非整倍体的第一层筛查提供，费用为 175 欧元。吸收率约为 50%。对于传统上谨慎的荷兰系统，这种放映优惠被认为是非常规的。